Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooks Jackson

Showing results (91-100 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Infectious Diseases|June 9, 2005
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVPSusan H Eshleman, Donald R Hoover, Shu Chen, et al.
AIDS (London, England)|November 15, 2005
Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newbornsSusan H Eshleman, Donald R Hoover, Shu Chen, et al.
Journal of Virology|July 17, 2009
Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapyCarlum Shiu, Coleen K Cunningham, Thomas Greenough, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2010
Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infantsIrene R Lubega, Mary Glenn Fowler, Philippa M Musoke, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2008
Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan childrenPhilippa M Musoke, Alicia M Young, Maxensia A Owor, et al.
The Journal of Infectious Diseases|June 9, 2005
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012Tamara Flys, Dwight V Nissley, Cassidy W Claassen, et al.
Drug and Alcohol Dependence|July 8, 2014
Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and ThailandGregory M Lucas, Alicia Young, Deborah Donnell, et al.
The Journal of Infection|July 13, 2006
Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, ChinaYuanzhi Zhang, Hua Shan, Jennifer Trizzino, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2009
Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, UgandaCarolyne Onyango-Makumbi, Danstan Bagenda, Antony Mwatha, et al.
Hepatitis Research and Treatment|May 27, 2014
Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and ThailandJ Brooks Jackson, Liu Wei, Fu Liping, et al.
Pageof 14

Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Infectious Diseases|June 9, 2005
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVPSusan H Eshleman, Donald R Hoover, Shu Chen, et al.
AIDS (London, England)|November 15, 2005
Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newbornsSusan H Eshleman, Donald R Hoover, Shu Chen, et al.
Journal of Virology|July 17, 2009
Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapyCarlum Shiu, Coleen K Cunningham, Thomas Greenough, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2010
Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infantsIrene R Lubega, Mary Glenn Fowler, Philippa M Musoke, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2008
Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan childrenPhilippa M Musoke, Alicia M Young, Maxensia A Owor, et al.
The Journal of Infectious Diseases|June 9, 2005
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012Tamara Flys, Dwight V Nissley, Cassidy W Claassen, et al.
Drug and Alcohol Dependence|July 8, 2014
Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and ThailandGregory M Lucas, Alicia Young, Deborah Donnell, et al.
The Journal of Infection|July 13, 2006
Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, ChinaYuanzhi Zhang, Hua Shan, Jennifer Trizzino, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2009
Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, UgandaCarolyne Onyango-Makumbi, Danstan Bagenda, Antony Mwatha, et al.
Hepatitis Research and Treatment|May 27, 2014
Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and ThailandJ Brooks Jackson, Liu Wei, Fu Liping, et al.
Pageof 14